Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-05

FDA Approved: OSMITROL — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Osmitol (mannitol) from Baxter Healthcare Company, indicating an update to its labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OSMITROL (mannitol)

Snippet

SUPPL AP for OSMITROL (MANNITOL)